Celestica (CLS) Tops Q4 EPS by 7c; offers guidance

Celestica (NYSE: CLS) reported Q4 EPS of $1.11, $0.07 better than the analyst estimate of $1.04. Revenue for the quarter came in at $2.55 billion versus the consensus estimate of $2.51 billion.

GUIDANCE:

Celestica sees Q1 2025 EPS of $1.06-$1.16, versus the consensus of $1.00. Celestica sees Q1 2025 revenue of $2.475-2.625 billion, versus the consensus of $2.44 billion.

Celestica sees FY2025 EPS of $4.75, versus the consensus of $4.48. Celestica sees FY2025 revenue of $10.7 billion, versus the consensus of $10.661 billion.

For earnings history and earnings-related data on Celestica (CLS) click here.

You May Also Be Interested In

• Privia Health Group, Inc. (PRVA) Tops Q3 EPS by 12c ; Offers Guidance
• Climb Bio, Inc. (CLYM) Tops Q3 EPS by 2c
• Climb Bio, Inc. (CLYM) Tops Q3 EPS by 2c